Business Context and Reporting Period
This Form 8-K Current Report from Flowserve Corporation covers events occurring on May 14, 2026. The filing details the results of the Company's 2026 Annual Meeting of Shareholders and a concurrent amendment to the Company's By-Laws approved by the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes rather than financial performance.
Material Changes and Governance Actions
- By-Law Amendment: The Board amended Article III, Section 2 of the By-Laws to decrease the number of directors from eleven to nine, effective May 14, 2026.
- Shareholder Meeting Attendance: The 2026 Annual Meeting was held virtually. 116,322,393 shares were present, representing 91.02% of the 127,795,413 shares entitled to vote.
- Director Elections: All nine director nominees were duly elected for terms expiring in 2027. Voting support ranged from approximately 93.5% (Thomas B. Okray) to 95.3% (Ruby R. Chandy).
- Executive Compensation: The advisory vote on executive compensation was approved with 103,981,326 votes FOR and 6,568,078 votes AGAINST.
- Auditor Ratification: Shareholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026.
- Shareholder Proposal Outcome: A shareholder proposal requesting an annual advisory vote on stock repurchases did not pass. It received 4,009,237 votes FOR and 105,292,037 votes AGAINST.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, or specific risk factors. The document is limited to reporting the procedural outcomes of the annual meeting and the by-law amendment.
Investor Verification Checklist
- Verify the updated Board composition of nine directors as reflected in the amended By-Laws (Exhibit 3.1).
- Confirm the re-election of all nine director nominees and their respective term expiration dates (2027).
- Note the significant shareholder rejection of the proposal for annual advisory votes on stock repurchases.
- Review the full text of the amended By-Laws filed as Exhibit 3.1 for details on the reduction in board size.